Acetylsalicylic Acid
MCA - Middle Cerebral Artery Dissection
Daewoong Pharmaceutical Co. LTD.Dormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the MCA - Middle Cerebral Artery Dissection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Plavix Daewoong Pharmaceutical Co. LTD. | D |
Same molecule, other indications
Acetylsalicylic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →